Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$3.4 - $4.24 $46,355 - $57,808
-13,634 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$3.76 - $5.14 $37 - $51
10 Added 0.07%
13,634 $57,000
Q1 2021

May 14, 2021

SELL
$4.81 - $8.74 $28,595 - $51,959
-5,945 Reduced 30.38%
13,624 $68,000
Q4 2020

Feb 25, 2021

BUY
$5.03 - $6.31 $5,080 - $6,373
1,010 Added 5.44%
19,569 $102,000
Q2 2020

Aug 14, 2020

BUY
$3.06 - $7.06 $56,790 - $131,026
18,559 New
18,559 $101,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.